🇦🇺Australia
GMP CAPA Non-Compliance Fines
2 verified sources
Definition
Inadequate CAPA management in deviation investigations triggers TGA GMP compliance failures, resulting in batch rejections, rework, and inspection deficiencies.
Key Findings
- Financial Impact: AUD 20,000-100,000 per GMP violation (batch rejection + rework costs); typical 2-5% production loss from deviations[3][6]
- Frequency: Per TGA inspection or deviation event
- Root Cause: Manual CAPA processes fail root cause analysis and timely closure, violating PIC/S standards
Why This Matters
This pain point represents a significant opportunity for B2B solutions targeting Pharmaceutical Manufacturing.
Affected Stakeholders
Quality Manager, Manufacturing Head, Compliance Officer
Action Plan
Run AI-powered research on this problem. Each action generates a detailed report with sources.
Methodology & Sources
Data collected via OSINT from regulatory filings, industry audits, and verified case studies.
Related Business Risks
CAPA Rework and Investigation Overheads
AUD 40 hours/month manual investigation time (at AUD 100/hr = AUD 4,000/month); 10-20% cost overrun from rework[1]
TGA Non-Compliance Fines
AUD 20,000 - 500,000 per violation; 2-5% production downtime costs
Cost of Poor Quality from Trending Failures
AUD 100,000+ per failed batch; 1-3% of production costs
Idle Capacity from Review Delays
AUD 5,000-10,000/day idle bioreactor; 5-10% capacity loss
Kosten durch TGA-GMP-Abweichungen bei Änderungsdokumentation
Estimated: AUD 70,000–250,000 per major GMP inspection cycle in extra remediation labour, consulting and TGA‑driven compliance costs due to deficient change control documentation.
Produktivitätsverlust durch manuelle Änderungsdokumentation
Estimated: 400–1,200 hours/year of QA and production time, equivalent to approximately AUD 32,000–144,000 per year in lost productive capacity due to manual change control documentation.